Varian forms Japanese subsidiary
Varian Associates of Palo Alto, CA, has beefed up its presence in Japan by forming a new subsidiary, Varian Japan KK, to market its instrumentation, semiconductor, and medical imaging products. Varian Japan replaces Varian Japan Ltd., a U.S. company with
Varian Associates of Palo Alto, CA, has beefed up its presence in Japan by forming a new subsidiary, Varian Japan KK, to market its instrumentation, semiconductor, and medical imaging products. Varian Japan replaces Varian Japan Ltd., a U.S. company with a branch office in Japan, which mostly handled sales of Varian's analytical and scientific instruments. The new subsidiary will handle Varian's x-ray tube business, while the company's cancer-therapy products will continue to be handled by a separate joint venture and Varian's distributor.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
